论文信息 - First-in-Human Study of the EZH1/2 Dual Inhibitor DS-3201b in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas — Preliminary Results - 字舞流文

First-in-Human Study of the EZH1/2 Dual Inhibitor DS-3201b in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas — Preliminary Results

A. Utsunomiya | K. Tobinai | D. Maruyama | K. Tsukasaki | K. Ishitsuka | S. Takeuchi | M. Yoshimitsu | T. Ishida | Y. Imaizumi | S. Kusumoto | K. Araki | Y. Sawayama | S. Makita | S. Fujitani